Vitamin D as an early predictor of multiple sclerosis activity and progression.
Alberto Ascherio
(1)
,
Kassandra L. Munger
(1)
,
Rick White
(2)
,
Karl Köchert
(3)
,
Kelly Claire Simon
(1)
,
Chris H. Polman
(4)
,
Mark S. Freedman
(4)
,
Hans-Peter Hartung
(4)
,
David H. Miller
(5)
,
Xavier Montalbán
(6)
,
Gilles Edan
(7)
,
Frederik Barkhof
(4)
,
Dirk Pleimes
(8)
,
Ernst-Wilhelm Radü
(9)
,
Rupert Sandbrink
(10, 11)
,
Ludwig Kappos
(12)
,
Christoph Pohl
(8)
1
HMS -
Harvard Medical School [Boston]
2 UBC - University of British Columbia
3 Bayer HealthCare, Berlin
4 CRMBM - Centre de résonance magnétique biologique et médicale
5 PARSIFAL - Proof search and reasoning with logic specifications
6 Vall d'Hebron University Hospital [Barcelona]
7 VisAGeS - Vision, Action et Gestion d'informations en Santé
8 Dept. of Radiology, VU Medical Center
9 University Hospital Basel [Basel]
10 Department of Neurology
11 Bayer HealthCare AG
12 Clinical Neuroimmunology, Department of Biomedicine, University of Basel, Basel
2 UBC - University of British Columbia
3 Bayer HealthCare, Berlin
4 CRMBM - Centre de résonance magnétique biologique et médicale
5 PARSIFAL - Proof search and reasoning with logic specifications
6 Vall d'Hebron University Hospital [Barcelona]
7 VisAGeS - Vision, Action et Gestion d'informations en Santé
8 Dept. of Radiology, VU Medical Center
9 University Hospital Basel [Basel]
10 Department of Neurology
11 Bayer HealthCare AG
12 Clinical Neuroimmunology, Department of Biomedicine, University of Basel, Basel